Bionano Genomics files $8.7M registered direct offering of common stock and warrants

Bionano Genomics, Inc.

Offering includes 6,536,682 common shares, pre-funded warrants for 2,196,944 shares, and warrants for 8,733,626 shares.
Pre-funded warrants allow purchase of common stock at a nominal exercise price; warrants have exercise price and term set in prospectus.
Legal opinion from Cooley LLP on validity of shares and warrant shares filed as Exhibit 5.1.
Proceeds intended for general corporate purposes; no specific pricing or discount disclosed in this 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.